Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity …
MTJ Quimque, KIR Notarte… - Journal of …, 2021 - Taylor & Francis
The novel coronavirus SARS-CoV2, the causative agent of the pandemic disease COVID-
19, emerged in December 2019 forcing lockdown of communities in many countries. The …
19, emerged in December 2019 forcing lockdown of communities in many countries. The …
ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread worldwide and become pandemic with thousands new deaths and infected cases …
spread worldwide and become pandemic with thousands new deaths and infected cases …
Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (Mpro) inhibitor using docking and molecular dynamics simulations
Abstract Novel SARS-CoV-2, an etiological factor of Coronavirus disease 2019 (COVID-19),
poses a great challenge to the public health care system. Among other druggable targets of …
poses a great challenge to the public health care system. Among other druggable targets of …
Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro)
The current coronavirus (SARS-COV-2) pandemic and phenomenal spread to every nook
and cranny of the world has raised major apprehensions about the modern public health …
and cranny of the world has raised major apprehensions about the modern public health …
[HTML][HTML] Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and …
Recently emerged SARS-CoV-2 caused a major outbreak of coronavirus disease 2019
(COVID-19) and instigated a widespread fear, threatening global health safety. To date, no …
(COVID-19) and instigated a widespread fear, threatening global health safety. To date, no …
Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic
Z Fakhar, B Faramarzi, S Pacifico… - Journal of Biomolecular …, 2021 - Taylor & Francis
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread worldwide and become pandemic with thousands new deaths and infected cases …
spread worldwide and become pandemic with thousands new deaths and infected cases …
In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors
MAA Ibrahim, AHM Abdelrahman… - Journal of biomolecular …, 2021 - Taylor & Francis
Herein, the DrugBank database which contains 10,036 approved and investigational drugs
was explored deeply for potential drugs that target SARS-CoV-2 main protease (Mpro) …
was explored deeply for potential drugs that target SARS-CoV-2 main protease (Mpro) …
Evaluation of clove phytochemicals as potential antiviral drug candidates targeting SARS-CoV-2 Main protease: computational docking, molecular dynamics …
A Chandra Manivannan, A Malaisamy… - Frontiers in Molecular …, 2022 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can cause a
sudden respiratory disease spreading with a high mortality rate arising with unknown …
sudden respiratory disease spreading with a high mortality rate arising with unknown …
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
The present-day world is severely suffering from the recently emerged SARS-CoV-2. The
lack of prescribed drugs for the deadly virus has stressed the likely need to identify novel …
lack of prescribed drugs for the deadly virus has stressed the likely need to identify novel …
[HTML][HTML] Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds
I Antonopoulou, E Sapountzaki, U Rova… - Computational and …, 2022 - Elsevier
The emergence of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
has resulted in a long pandemic, with numerous cases and victims worldwide and enormous …
has resulted in a long pandemic, with numerous cases and victims worldwide and enormous …
相关搜索
- sars cov main protease
- sars cov drug repurposing
- sars cov potent inhibitors
- sars cov molecular dynamics
- viral attachment sars cov2
- viral attachment drug discovery
- viral attachment enzyme inhibitors
- enzyme inhibitors sars cov2
- drug discovery sars cov2
- drug discovery enzyme inhibitors
- sars cov therapeutic targets
- sars cov screening strategies
- sars cov covid 19
- sars cov nsp12 polymerase
- sars cov antiviral phytochemicals
- sars cov computational docking